---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-320242"
form_type: "8-K"
ticker: "TEVA"
cik: "0000818686"
company_name: "TEVA PHARMACEUTICAL INDUSTRIES LTD"
filed_at: "2021-11-04T23:59:59+00:00"
generated_at: "2026-06-28T13:30:01.216277+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Teva prices $5B equivalent sustainability-linked notes; proceeds to repay debt

## Summary
- Teva upsized and priced €1.1B 3.75% notes due 2027, €1.5B 4.375% notes due 2030, $1B 4.75% notes due 2027, and $1B 5.125% notes due 2029.
- Largest-ever sustainability-linked note offering and first by a generic medicine company; tied to access-to-medicines and GHG targets.
- Net proceeds to fund tender offer for up to $3.5B of existing senior notes maturing 2022-2024 and for general corporate purposes.
- Settlement expected November 9, 2021; notes are unsecured senior obligations guaranteed by Teva.

## SEC filing metadata
- accession: 0001193125-21-320242
- form_type: 8-K
- ticker: TEVA
- cik: 0000818686
- company_name: TEVA PHARMACEUTICAL INDUSTRIES LTD
- filed_at: 2021-11-04T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818686/000119312521320242/0001193125-21-320242-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818686/000119312521320242/d599039d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-320242
- JSON: https://secwatch.observer/filing/0001193125-21-320242.json
- Plain text: https://secwatch.observer/filing/0001193125-21-320242.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.